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Abstract 17
The double membrane architecture of Gram-negative bacteria forms a barrier 18 that is effectively impermeable to extracellular threats. Accordingly, researchers have 19
shown increasing interest in developing antibiotics that target the accessible, surface-20 exposed proteins embedded in the outer membrane. TolC forms the outer membrane 21 channel of an antibiotic efflux pump in Escherichia coli. Drawing from prior observations 22 that colicin E1, a toxin produced by and lethal to E. coli, can bind to the TolC channel, 23
we investigate the capacity of colicin E1 fragments to 'plug' TolC and inhibit its efflux 24 function. First, using single-molecule fluorescence, we show that colicin E1 fragments 25 that do not include the cytotoxic domain localize at the cell surface. Next, using real-time 26 efflux measurements and minimum inhibitory concentration assays, we show that 27 exposure of wild-type E. coli to fragments of colicin E1 indeed disrupts TolC efflux and 28 heightens bacterial susceptibility to four common classes of antibiotics. This work 29 demonstrates that extracellular plugging of outer membrane transporters can serve as a 30 novel method to increase antibiotic susceptibility. In addition to the utility of these protein 31 fragments as starting points for the development of novel antibiotic potentiators, the 32 variety of outer membrane protein colicin binding partners provides an array of options 33 that would allow our method to be used to inhibit other outer membrane protein 34 functions. 35
36
Significance 37 We find that fragments of a protein natively involved in intraspecies bacterial 38 warfare can be exploited to plug the E. coli outer membrane antibiotic efflux machinery. 39
This plugging disables a primary form of antibiotic resistance. Given the diversity of 40 bacterial species of similar bacterial warfare protein targets, we anticipate that this 41
Introduction
In Gram-negative bacteria, the concentric structures of the outer membrane, cell 48 wall, and cytoplasmic membrane protect the cell from extracellular threats. Of these 49 protective structures, the outer membrane is a particularly formidable barrier (1), owing 50 to the impermeable structure of the lipopolysaccharide (LPS) that constitutes the outer 51 membrane's outer leaflet (2). The primary means by which external molecules can gain 52 access to the cell is through the ~100 varieties of barrel-shaped proteins that are 53 embedded in each bacterium's outer membrane (outer membrane proteins, OMPs) (3), 54 and whose diverse functions include the transport of molecules across the membrane-55 specifically, the import of nutrients and metabolites and the export of toxins and waste. 56
Because they are accessible from outside the cell, OMPs are attractive targets for 57 the development of novel antibiotics, and research in this vein has begun to reveal the 58 therapeutic potential of interfering with OMP structure and function. One recent study in 59 Escherichia coli, for example, showed that exposing bacteria to a monoclonal antibody 60 that inhibits OMP folding produces bactericidal effects (4). An alternative approach for 61 targeting OMPs is the development of molecular plugs that block the pores of these 62 proteins: such a plug would allow for the manipulation of bacterial transport, providing a 63 means of either starving the bacterium (by preventing the influx of valuable nutrients) or 64 poisoning it (by preventing the outflow of toxins). This idea of blocking the channel of 65 outer membrane efflux pumps has been previously proposed for increasing bacterial 66 susceptibility to antibiotics (5). However, no successful examples to date have been 67
reported. 68
In this study, we find that fragments of colicin E1-a bactericidal toxin produced by 69 and lethal to E. coli-can block the capacity of TolC, an OMP in E. coli, to eliminate 70
antibiotics. 71
TolC is the outer membrane component of the acridine efflux pump (along with AcrA 72 in the periplasm and AcrB in the inner membrane) (6), which extrudes multiple classes of 73 antibiotics such as erythromycin, chloramphenicol, tetracycline, doxorubicin, and 74 acriflavine (7, 8), as well as other compounds such as bile salts and detergents (9). 75
Deletion of TolC has been shown to render E. coli vulnerable to a wide variety of 76 antibiotics (10). Moreover, expression of TolC is linearly correlated to antibiotic 77 resistance in clinical isolates of E. coli (11). These observations suggest that identifying 78 means of targeting TolC might provide insights that can contribute towards disabling 79 antibiotic resistance, which is becoming a world-wide threat (12, 13) . 80
Colicins are E. coli-specific bacteriocins, which are protein toxin systems through 81 which bacteria engage in 'bacterial warfare' with other, similar bacteria. Bacteriocins 82 hijack the OMPs of a target bacterium to cross its impermeable outer membrane and kill 83 the bacterium. E. coli produces numerous types of colicins, which vary in their receptor 84 targets and killing mechanisms. Yet, all colicins share a common triadic domain 85 architecture, comprising the following components: (i) an N-terminal translocation (T) 86 domain, (ii) a receptor-binding (R) domain, and (iii) a C-terminal cytotoxic (C) domain 87 ( Fig. 1A) . Colicin import is initialized by the binding of the R domain to an OMP target 88 with high affinity (14, 15) ; this binding localizes the colicin onto the outer membrane. 89
Once colicin is tethered to the outer membrane surface, the T domain initiates 90 translocation using a secondary OMP receptor that is, in most cases, distinct from the R 91 domain's OMP target (16) . Colicin E1 uses TolC as the receptor of the T domain and 92
BtuB as the receptor of the R domain (17). 93
Prior studies have suggested that segments of colicin E1's T domain can bind the 94 TolC channel (18). In particular, peptides including residues 100-120 of colicin E1 95 (termed the 'TolC box'), with additional amino acids at the C-terminus of the 'box', have 96 been shown to co-elute with TolC (18) and to disrupt channel conductance (19) . A 97 subsequent study confirmed the identity of the minimal T-domain segment that binds 98
TolC, showing that E. coli exposure to peptides comprising residues 100-120 is 99 sufficient to prevent subsequent binding of full-length colicin E1 (as reflected in the fact 100 that the bacteria were protected from the colicin's cytotoxic effects (20)). Notably, none 101 of these studies investigated the effects of exposure to colicin E1 fragments on TolC's 102 efflux activity. 103 Accordingly, here we use specific fragments of colicin E1 to determine whether the 104 binding event between the N-terminal T domain and the TolC pore can disrupt the 105 OMP's native export function. In particular, we suggest that this binding event is likely to 106 plug the pore, in light of observations, obtained through circular dichroism, that colicin E1 107 inserts into the TolC β-barrel as a helical hairpin (18). The proposed plugging 108 mechanism is further supported by co-crystal structures of colicin E3 and E9 fragments 109 bound to the outer membrane porin OmpF, which revealed that the peptides obstruct the 110
OmpF barrel (21, 22) . 111
We investigate minimal truncations of colicin E1 that include the entirety of the T and 112 R domains (colE1-TR), the T domain alone (colE1-T), and a peptide containing residues 113 100-143 (colE1-T 100-143 ), i.e., the TolC box together with 23 additional residues ( Fig. 1B) . 114
Inclusion of the additional residues in the latter peptide was motivated by the observation 115 that colE1-T forms a helical hairpin and that colicin E1 is theorized to also insert into 116
TolC as a helical hairpin (23), and a transmembrane hairpin requires ~43 amino acids. 117 Colicin localization was probed through western blot analysis of specific colicin 146 fragments with C-terminal polyhistidine-tags. Cells were incubated with these colicin 147 fragments and subsequently exposed to two increasing concentrations of trypsin. If the 148 protein enters the cell, the outer membrane shields it from trypsin digestion and a 149 corresponding band is present on the western blot under conditions with trypsin (intact 150 cell condition). Periplasmic protein SurA was used as a membrane integrity control to 151 identify if trypsin entered cells. As a trypsin activity control, half of the cell sample was 152 lysed (lysed cell condition) exposing all cellular compartments to trypsin. 153
When we probed colE1-T for interaction with the cell, there was no detectable 154 level of the protein either in the presence or in the absence of trypsin (Fig. 1C, left) , 155
indicating lack of binding. When cells were incubated with colE1-TR, a band 156 corresponding to colE1-TR appeared on intact cells that were not exposed to trypsin. 157 When we increased the amount of trypsin, colE1-TR was digested at each trypsin 158 concentration, indicating that the colicin E1 fragment was localized to the outer 159 membrane surface (Fig. 1C, right) . In contrast, the control, periplasmic chaperone SurA, 160
was not degraded at any trypsin concentration unless the cells were lysed before the 161 digestion reaction (24). 162
After determining that colE1-TR remains at the cell surface, we probed binding 163 and cell localization through single-molecule fluorescence microscopy. C-terminal 164 cysteines were incorporated into colE1-T and colE1-TR to enable thiol coupling to the 165 fluorescent dye cyanine 3 (Cy3). When colE1-TR-Cy3 was added to the extracellular 166 environment of WT BW25113 E. coli cells (containing TolC), distinct puncta ( Fig. 1D,  167 left) formed on 94% of the cells (n = 111) ( Fig. 1E ). In strain JW5503-1, a population of 168 cells lacking TolC (ΔtolC), puncta were observed in only 18% of cells (n = 99) ( Fig. 1D,  169 right, Fig. 1E ). In WT and ΔtolC cells that did feature puncta, colE1-TR formed clusters 170 of 12-20 molecules per punctum, where each cluster had a diameter of less than the 171 microscope's 0.5 μm resolution. The quantity of molecules and the size of the puncta 172 were in agreement with previous studies of BtuB clusters (25, 26), supporting the 173 assumption that the puncta comprised clusters of colE1-TR bound to BtuB. We further 174 verified that punctum formation and localization was not an artifact of Cy3 conjugation: a 175 fusion construct of GFP to the C-terminus of colE1-TR also displayed the same cluster 176 formation characteristics ( Fig. 1E , SI Appendix, Fig. S1A ). No other single protein 177 binding events were detected aside from the observed puncta formation in either WT or 178
ΔtolC cells. A ΔbtuB strain is not commercially available. Both strains of the Keio 179 collection marked ΔbtuB were found to have reverted by the Coli Genetic Stock Center 180 (personal communication). Although there have been truncations described in the 181 literature, we anticipate that at least some of the protein is required for survival. 182
Colicin constructs lacking the R domain (colE1-T-Cy3) showed no detectable 183 binding either to WT cells containing TolC or to the TolC knockout strain of cells (SI 184 Appendix, Fig. S1B ), indicating that the TolC:colE1-T interaction is much weaker than 185 the BtuB:colE1-TR interaction. Moreover, when we observed time courses of bound 186 colE1-TR, all puncta remained immobile for > 5 minutes (Movie S1), further supporting 187 the proposition that colE1-TR does not translocate (27) cell-based experiments, we wanted to ensure that our colicin E1 constructs indeed bind 199
to TolC in vitro. The interaction of TolC and colicin E1 fragments has previously been 200 characterized in vitro through co-elution of the peptides by size exclusion chromatograph 201 (SEC) (18). We used a similar approach and assessed peak shifts for both colE1-T and 202 colE1-TR when mixed with TolC. ColE1-T alone and TolC alone eluted from the SEC at 203 14.7 mL and 10.7 mL, respectively ( Fig. 2A, right) . When the two were mixed together, 204
we observed shift in the TolC peak to 10.2 mL and a decrease in intensity associated 205 with the colE1-T peak indicating that a subset of the population has migrated with TolC. 206
We analyzed the peak (arrow) using sodium dodecyl sulfate polyacrylamide gel 207 electrophoresis (SDS-PAGE) ( Fig. 2A, left) and found the presence of both colE1-T (red 208 triangle) and TolC (purple triangle), indicating the colE1-T co-elutes with TolC. ColE1-TR 209 precipitates in the NaCl concentration (40 mM) used to co-elute colE1-T so we increased 210 colE1-T are mixed there is a smaller peak shift and the presence of a shoulder (Fig. 2B,  212 right). Although we could detect binding, the higher salt concentration prevents full 213 binding as indicated by a much fainter band for colE1-T (Fig. 2B, left) . 214
When TolC and colE1-TR were mixed (Fig. 2C, right) , we observed a peak shift 215 from 11.0 mL for colE1-TR alone to 10.0 mL for colE1-TR in the presence of TolC. The Active efflux can then be monitored by the decay in fluorescent signal once proton 227 motive force is reenergized by the addition of glucose (29) (30) (31) (32) (33) . 228
We assessed the ability of colicin E1 truncations to plug TolC by monitoring real-229 time efflux of NNN. Cells exposed to colE1-T 100-143 (comprising colicin E1 residues 100-230 143; Fig. 1B ) did not show lower real-time efflux of the fluorescent probe molecule NNN 231 (i.e., weaker decay in fluorescence), as compared with untreated cells (Fig. 3A) . This 232 observation is notable in light of the fact that, in previous studies, similar peptides were 233
shown to bind TolC (18, 20) and to occlude the channel, as reflected in diminished 234 conductance (18, 19) . These 235 studies, however, did not 236 investigate the effects of colicin E1 237 fragments on the efflux function of 238 the pump. 239 macrolides, and quaternary ammonium 261 compounds, respectively). Specifically, 262
WT E. coli cells that were exposed to 263 100 μM colE1-TR in combination with 264 each of these antibiotic substances 265 showed substantially lower MICs (Fig. 4 ) 266 compared with cells exposed to the 267 antibiotics alone: Exposure to 100 μM 268 colE1-TR made WT E. coli ~1.5-2.0-fold 269 more susceptible to these antibiotics (SI 270
Appendix, Table S1 ). and proposed that the colicin might also 282 serve as a molecular plug that disrupts the channel's native efflux function, which 283 facilitates the elimination of antibiotics. We found that a fragment of colicin E1 that lacks 284 Fig. 4 : ColE1-TR makes antibiotics more potent: Antibiotic susceptibility was determined in the absence (green) and presence of colE1-TR at 1 μM (blue), 10 μM (purple), 25 μM (pink), 50 μM (orange), 100 μM (yellow) for erythromycin, ciprofloxacin, kanamycin, and benzalkonium chloride in E. coli WT. MICs for ΔtolC (red) are included as a reference for total loss of TolC. For kanamycin, the MIC for ΔtolC was not determined since the deletion of the tolC gene is accomplished by insertion of a kanamycin resistance cassette. Kanamycin was collected with more replicates as the data was more variable. All data for WT were collected with biological replicates, and error bars correspond to the standard error of the mean. Clusters indicated have a statistically significant difference in their mean values relative to WT (* with P < .050, ** with P < .010, *** with P < .001) the cytotoxic C domain potentiates antibiotics of various classes, including 285 aminoglycosides, fluoroquinolones, macrolides, and quaternary ammonium compounds. 286
We first showed that colicin E1 truncations composed of the T or the TR 287 domains, without the C domain, do not fully enter into cells. Through single-molecule 288 microscopy we were able to observe the TR domain bind to the WT cell surface. In 289 contrast, for colE1-T, a truncation that did not include the R domain, we did not observe 290 binding to the cell surface. Notably, however, TolC binding did seem to have a significant 291 role in the binding of colE1-TR to the cell surface: binding occurred in a substantially 292 higher proportion of WT E. coli than in cells deleted of TolC. In ΔtolC cells, the few 293 binding events that were observed were localized to puncta, and were assumed to 294 reflect binding of the R domain to BtuB. Taken together, these observations suggest that 295 the T domain:TolC interaction enhances colicin E1's ability to stay bound to the surface 296 but is not sufficient on its own to show binding events. Indeed, this proposition is 297 supported by the results of the real-time efflux functional assay, where colE1-T only 298 partially inhibited efflux of antibiotics, whereas colE1-TR achieved full inhibition. We infer 299 from these observations that the relative affinity of the T domain for TolC is weaker than 300 the affinity of the R domain to BtuB. Avidity by the additional interaction of the R domain 301 with BtuB is required for full inhibition of efflux. This is not surprising since colicin E1 302 functions as part of a mechanism to deliver a cytotoxic domain and not specifically for 303
TolC plugging. 304
In addition to pointing to a means of manipulating TolC efflux, our observations 305 enable us to draw conclusions regarding the mechanism of efflux inhibition. Previous 306 functional studies have proposed two alternative models for colicin E1's utilization of 307
TolC to enter and poison the cell (18, 34). The first is the 'total thread' model in which the 308 entire colicin is unfolded, and TolC serves as a channel for it to thread through (34). The 309 second, 'pillar' model, based on structural studies of the binding interaction between 310
TolC and N-terminal peptides of colicin E1, proposes that colicin E1 inserts into TolC as 311 a helical hairpin, which serves as a buttress to facilitate the entry of the colicin's cytotoxic 312 domain (18). In this model, the intrinsic properties of the cytotoxic domain itself are 313 proposed to allow it to cross the outer membrane, potentially with mediation by anionic 314 LPS. The results presented herein support the latter model. Specifically, we observed 315 that, without the cytotoxic domain, colE1-TR remains stalled on the outer membrane 316 exposed to the extracellular environment, instead of entering the cell, as would be 317 expected with the total thread model. 318
Accordingly, we propose the following mechanism of efflux inhibition based on 319 the Cramer 'pillar' model of colicin E1 interaction with BtuB and TolC. First, the R domain 320 binds to BtuB with high affinity and acts as an anchoring point for the colicin on the cell 321 membrane (Fig. 5A) . Second, the T domain is able to search for TolC and insert into the 322 channel, stabilizing its association with the membrane and, more importantly, forming a 323 plug that blocks the 324 exit of TolC 325 substrates (Fig. 5B) . 326
Since the 327 presence of TolC 328 enhances puncta 329 formation, both 330
BtuB and TolC need 331 to be in close 332 proximity for binding 333 to occur. Given that 334
BtuB clusters together-potentially excluding TolC-the number of full binding sites 335 available for the T and R domains of colicin E1 may be substantially lower than simply 336
Fig. 5: Model of colE1-TR inhibition of efflux.
The R domain of colE1-TR (orange) binds to BtuB (cyan) with high affinity and anchors colE1-TR to the surface of the cell. The T domain (red) then inserts into TolC (lavender), plugging the channel and blocking exit of antibiotics (spheres). We only see this interaction when 12 or more colE1-TR bind in the same cluster. (A) Before binding, antibiotics are effluxed (B) the pillar model is depicted as a possible binding configuration that prevents efflux. the number of TolC or BtuB proteins. In principle, the resolution of our microscopy 337 experiments can detect single binding events, yet we only observe puncta with 12 338 binding events or more of colE1-TR to the cell surface. We speculate that there may be 339 geometric constraints on a cluster. It may be the case that there are not sufficient TolC 340
and BtuB oriented in such a way that at least 12 ligands can bind to both TolC and BtuB 341 at once. To understand the order of the geometric constraint, we can create a simple 342 model of the problem as a six by four grid allowing for 12 TolCs and 12 BtuBs. If each of 343 these 24 proteins can be placed in any configuration on the grid, this results in the 344 number of possible configurations at 24 choose 12 equals 2,704,156 (SI Appendix, 345 methods). The number of configurations in which all 12 TolCs would be adjacent to a 346
BtuB is a small percentage of these configurations. Using the Hopkraft-Karp algorithm 347 (SI Appendix, methods) we determined how many of these conformations would have all 348
TolC paired to a BtuB by being in one of BtuB's eight adjacent squares. We find only 349 262,912 confirmations or 10% of the total possible arrangements--suggesting that the 350 availability for binding within a cluster is a low probability event. 351
Though it seems that colicin E1 confers a dose response of antibiotic 352 potentiation, the relatively high concentration of colE1-TR needed to significantly inhibit 353 efflux may be at least partially explained by these geometric considerations as well as by 354 other binding concerns. Although previous studies have identified nanomolar affinities 355 between BtuB and the R domain of colicin E3 (14, 35) , in a competition assay where 356 excess BtuB was shown to protect cells from colicin E3, no protection from colicin E1 357 was observed, even at 200 molar excess (36). The latter observation indicates that the 358 binding affinity between colicin E1 and BtuB is lower than that between colicin E3 and 359
BtuB, and may reflect the fact that, as observed here, TolC has a significant role in 360 colicin E1 binding. At an OD 600 = 1 we anticipate approximately 8 x 10 8 E. coli cells, each 361 with approximately 400 BtuBs (37) and 1,500 trimeric TolCs (38). A back-of-the-362 envelope calculation indicates that at a 100μM concentration, colE1-TR has 50,000 363 colE1-TR domains for every TolC pore in the sample. Though 10 μM colE1-TR was 364 sufficient to affect efflux of NNN, this quantity did not stop efflux completely, and was not 365 sufficient to heighten cells' sensitivity to antibiotics. Though we cannot explain why quite 366 such a high concentration is necessary for antibiotic potentiation, it is clear that for this 367 method of antibiotic potentiation to be useful the binding affinity between the T domain 368
and TolC will need to be increased. 369
Owing to their limited potency, our colE1-T and colE1-TR fragments are not likely 370 to be useful in direct practical applications of antibiotic potentiation. However, as a proof 371 of concept, our findings offer a potential roadmap for further development. A more potent 372 binder of TolC would not need the R domain anchor. If the interaction between TolC and 373 colE1-T can be resolved to atomic detail, the colicin T domain would serve as an ideal 374 candidate for optimization by computational methods and/or by directed evolution to 375 engineer an effective antibiotic potentiator to prevent the spread of antibiotic resistance. 376
Moreover, once the atomic structure of the interaction is known, proteins could be 377 designed for blocking efflux through outer membrane efflux pumps of at least five other 378 bacterial organisms. Each of these organisms have structurally characterized outer 379 membrane efflux pumps that have been shown to be homologous and structurally similar 380
to TolC (39). 381
More broadly, there are more than 20 known varieties of bacteriocins. These 382 bacteriocins are known to bind to different bacterial outer membrane proteins with a wide 383 variety of functions including: adhesion, iron transport, and general import (16, 40) . 384
Applying this method of inhibition using fragments derived from other colicins may 385 provide insight into inhibition of other bacterial function as well. Genes for colicin constructs (colE1-T, colE1-TR, colE1-T-E192C, colE1-TR-E366C, 398 colE1-TR-GFP) were cloned into pET303. Plasmids were transformed into BL21(DE3) 399 and proteins were expressed in TB media supplemented with 0.4% glycerol, 10 mM 400
MgCl2. Protein expression was induced with 1mM IPTG at 15 °C for 24 hours. Proteins 401 were purified by nickel affinity chromatography followed by gel filtration on an ÄKTA pure 402 chromatography system. 403
TolC 404
Full-length TolC was cloned into pTrcHis with a C-terminal 6x histidine tag and 405 transformed into BL21(DE3)Omp8. Protein expression was induced with 1mM IPTG at 406 25 °C for 24hrs. TolC was extracted from the membrane fraction with 1% n-dodecyl-β-D-407 maltoside at 4 °C for 24hrs and purified by nickel affinity chromatography followed by gel 408 filtration on an ÄKTA pure chromatography system. 409
410

Peptide Synthesis 411
ColE1-T 100-143 was synthesized using a CEM liberty blue microwave peptide synthesizer 412 using standard Fmoc chemistry. The peptides where cleaved using a solution of 413 92.5:2.5:2.5:2.5 TFA:TIPS:H2O:DoDt and the crude peptides where purified using 414 preparative HPLC. Analytical HPLC traces were acquired using an Agilent 1100 415 quaternary pump and a Hamilton PRP-1 (polystyrene-divinylbenzene) reverse phase 416 analytical column (7 μm particle size, 4 mm x 25 cm) with UV detection at 215 nm. The 417 eluents were heated to 45 °C to reduce separation of rotational isomers, and elution was 418 achieved with gradients of water/ acetonitrile (90:10 to 0:100 containing 0.1% TFA) over 419 20 min. Low-resolution mass spectra (LRMS) were obtained using a Waters Micromass 420 ZQ 4000 instrument with ESI+ ionization 421 422
Extracellular Protease Digestion 423
Protein localization after exogenous addition to whole cells was determined as 424 previously described (24). Briefly, colE1 protein constructs were incubated with whole 425 cells followed by trypsin digestion. If colE1 enters the cell it would be protected from 426 trypsin digest by the cell membrane. If colE1 remains localized to the outer membrane it 427 would by susceptible to trypsin digestion. The presence of ColE1 was probed through 428 western blot analysis. 429 430
Single-Molecule Microscopy 431
Cysteine mutants were labeled with Cyanine 3 (Cy3) through maleimide chemistry. 432 BW25113 or ΔtolC were mixed with Cy3 labeled colicin E1 (T or TR) or colE1-TR-GFP 433 and imaged (live and unfixed) using epifluorescence microscopy with sensitivity to detect 434 single dye molecules as described previously (41). Fluorescence was excited by a 561-435 nm laser (Coherent Sapphire 560-50) for Cy3 or a 488-nm laser (Coherent Sapphire 436 488-50) for GFP. Fluorescence was imaged with an Olympus IX71 inverted microscope 437 with a 100x, 1.40-NA oil-immersion objective. Images were captured with a Photometrics 438
Evolve electron multiplying charge-coupled device (EMCCD) camera. 439 440
Co-elution 441
The interaction of TolC and colicin E1 T or TR were determined by co-elution on an SEC 442 column. Purified TolC and colicin E1 T or TR were mixed at a 1:2 molar ratio and 443 incubated at room temperature for 1 hour before loading onto a Superdex 200 Increase 444 10/300 GL column (GE Healthcare). The protein was eluted with 1.5 column volumes 445 into 20 mM Tris pH 8.0, 40 mM NaCl, 0.05% n-dodecyl-β-D-maltoside for colE1-T. For 446 colE1-TR the NaCl concentration was increased to 200 mM to prevent precipitation. 447
Elution fractions were collected every 0.5 mL. Peak fractions were concentrated to 20 μL 448 and analyzed by SDS-PAGE. 449 450
Real-time Efflux 451
Real-time efflux activity in the presence of colE1-TR was determined as previously 452 described with some modifications (29, 30) . Cells were resuspended to in cold PBS with 453 and without 10-100 μM colicin proteins and incubated for 15 minutes on ice. 100μM 454 carbonyl cyanide m-chlorophenyl hydrazone (CCCP) was added to turn off efflux. After 455 an additional 15 minutes the efflux dye NNN was added to the cells to 10 μM. The cells 456 were incubated at 25 °C with shaking at 140 r.p.m. for 2 hours. Cells were harvested at 457 3,500g for 5 minutes and washed once in 20 mM potassium phosphate buffer pH 7 with 458 1mM MgCl 2 . Cell were loaded into a quartz cuvette (Agilent Technologies). Fluorescence 459
was measured with an Agilent Cary Eclipse fluorescence spectrophotometer with 460 excitation wavelength of 370 nm and emission wavelength of 415 nm. Fluorescence 461 measurements were taken every 1 second. After 100 seconds, 50 mM glucose was 462 added to re-energize the cells and initiate efflux, and fluorescence data were collected 463 for an additional 600 seconds. 464
465
MICs 466
MICs were determined using the broth dilution method in 96 well plate format using LB 467 media in 100 μL well volumes. Cultures were grown at 37 °C with shaking at 250 r.p.m. 468
and OD 600 was read on a Biotek plate reader after 20 hours. P values were determined 469 using a two-tailed Student's t-test in GraphPad Prism 7.0. 470 471 Acknowledgments
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